ColoradoPassed one chamber2026 Regular Session

SB26-140 Exempt Drugs from Prescription Drug Affordability Board Reviews

Latest: Apr 13, 2026 · House Committee on Health & Human Services Postpone Indefinitely

Contact your officials about this bill Sign in to follow

What it means

Our plain-English summary and constitutional analysis for this bill is not published yet. Every analysis is reviewed by an editor before it appears here.

How they voted

3 committee, procedural and amendment votes

House: Lay over the bill until May 15th.

11 yes · 0 no · 2 other

Apr 22, 2026 · Result: pass

Party	Yes	Other / excused
Democratic	7	1
Republican	4	1

How each member voted (13)

Open the member list

Party shown is each member's current party in our records. Official vote record

Senate: BILL

20 yes · 15 no

Apr 13, 2026 · Result: pass

Party	Yes	No
Democratic	8	15
Republican	12	–

How each member voted (35)

Open the member list

Party shown is each member's current party in our records. Official vote record

Senate: Refer Senate Bill 26-140 to the Committee of the Whole.

5 yes · 2 no

Apr 2, 2026 · Result: pass

Party	Yes	No
Democratic	3	2
Republican	2	–

How each member voted (7)

Open the member list

Party shown is each member's current party in our records. Official vote record

Where it stands

Mar 16, 2026 · Senate
Introduced
Introduced In Senate - Assigned to Health & Human Services
Apr 2, 2026 · Senate
Sent to committee
Senate Committee on Health & Human Services Refer Unamended to Senate Committee of the Whole
Apr 13, 2026 · Senate
Passed Senate
Senate Third Reading Passed - No Amendments
Apr 21, 2026 · House
Introduced
Introduced In House - Assigned to Health & Human Services

Full official history (8 actions)

Mar 16, 2026SenateIntroduced In Senate - Assigned to Health & Human Services
Apr 2, 2026SenateSenate Committee on Health & Human Services Refer Unamended to Senate Committee of the Whole
Apr 8, 2026SenateSenate Second Reading Laid Over to 04/09/2026 - No Amendments
Apr 9, 2026SenateSenate Second Reading Passed - No Amendments
Apr 10, 2026SenateSenate Third Reading Laid Over to 04/13/2026 - No Amendments
Apr 13, 2026SenateSenate Third Reading Passed - No Amendments
Apr 21, 2026HouseIntroduced In House - Assigned to Health & Human Services
Apr 22, 2026HouseHouse Committee on Health & Human Services Postpone Indefinitely

Supporters and opponents

No documented positions yet. Every position we list links to its public source.

Official summary

Read the official summary (openstates)

The bill states that the Colorado prescription drug affordability review board has no authority to perform an affordability review of, or to establish an upper payment limit for, a prescription drug that is:Designated as a drug for a rare disease or condition by the food and drug administration (FDA) of the federal department of health and human services; orA licensed biological product that is derived from human whole blood or plasma as indicated on product labeling approved by the FDA.(Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)